Streetbeat News

Price Targets

FDMT

4D Molecular Therapeutics shares are experiencing a decline after Leerink Partners reduced its price target from $40 to $36.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:03 pm

SUI

Wells Fargo analyst James Feldman maintains an Equal-Weight rating on Sun Communities (NYSE:SUI) and raises the price target from $123 to $154.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:03 pm

MRNA

RBC Capital analyst Luca Issi has reiterated a Sector Perform rating for Moderna (NASDAQ:MRNA) and maintained a price target of $75.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:01 pm

OUT

Outfront Media (NYSE:OUT) received mixed analyst ratings, with a recent average price target increase to $18.2. Analysts' ratings range from 'Overweight' to 'Hold', reflecting varied expectations for the company's performance. Outfront Media, a real estate investment trust, shows strong financial metrics like a high net margin and ROE, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 2:00 pm

MUSA

Murphy USA (NYSE:MUSA) has been analyzed by five analysts, showing a range of sentiments from somewhat bullish to somewhat bearish. The average 12-month price target has increased by 6.5% to $521.4. Analysts have adjusted their ratings and price targets, reflecting their views on Murphy USA's market performance. Despite a recent revenue decline, Murphy USA maintains strong financial health with high net margins, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 2:00 pm

OTIS

RBC Capital analyst Nicholas Housden has reiterated an Outperform rating for Otis Worldwide, maintaining a price target of $110.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:58 pm

PYXS

RBC Capital analyst Leonid Timashev has reiterated an Outperform rating for Pyxis Oncology (NASDAQ:PYXS) and maintained a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:55 pm

OUT

Wells Fargo has initiated coverage on Outfront Media with an Overweight rating and set a price target of $22.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:52 pm

RYAM

RBC Capital analyst Matthew McKellar has maintained an 'Outperform' rating on Rayonier Advanced Materials (NYSE:RYAM) and raised the price target from $9 to $10.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:50 pm

SSNC

RBC Capital analyst Daniel Perlin maintains an Outperform rating on SS&C Technologies Holdings (NASDAQ:SSNC) and raises the price target from $75 to $86.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:48 pm